Mountain View, CA, United States of America

Peter Milner

USPTO Granted Patents = 3 

Average Co-Inventor Count = 2.3

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations in Gastrointestinal Treatments by Peter Milner

Introduction

Peter Milner is an accomplished inventor based in Mountain View, CA, specializing in pharmaceutical formulations aimed at treating gastrointestinal disorders. With a total of 3 patents to his name, Milner has made significant contributions to the field of medicine.

Latest Patents

Milner's latest patents focus on pharmaceutical formulations and methods for the treatment of various gastrointestinal disorders. One notable patent describes a bulk composition comprising the trihydrate form of a specific compound designed to address conditions such as gastroesophageal reflux disease (GERD), dyspepsia, and irritable bowel syndrome (IBS). The formulations also target other gastrointestinal issues, including gastroparesis, post-operative ileus, and constipation. These innovative compositions aim to provide effective treatment options for patients suffering from these conditions.

Career Highlights

Peter Milner is currently associated with Renexxion, LLC, where he continues to develop groundbreaking solutions in the pharmaceutical industry. His work has been instrumental in advancing treatment methodologies for gastrointestinal disorders, showcasing his commitment to improving patient outcomes.

Collaborations

Milner has collaborated with notable colleagues, including Pascal Jean Druzgala and Jien Heh Tien, to further enhance the research and development of innovative treatments in the pharmaceutical sector.

Conclusion

Peter Milner's contributions to the field of gastrointestinal treatments through his patents and work at Renexxion, LLC highlight his dedication to advancing medical science. His innovative approaches are paving the way for more effective therapies for patients in need.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…